The KLOW peptide blend has become one of the most searched-for research peptide combinations in Australia. It brings four well-studied compounds together in a single lyophilised vial: BPC-157, GHK-Cu, TB-500 and KPV. This guide explains what is in a KLOW blend, what the published research reports for each component, how KLOW differs from the GLOW blend, and what to check before you buy one in Australia.
What is the KLOW peptide?
"KLOW" is not a single molecule. It is an informal name for a multi-peptide blend that combines four research compounds in fixed amounts. The Optic Labs KLOW80 blend contains:
- BPC-157 — 10mg
- GHK-Cu — 50mg
- TB-500 — 10mg
- KPV — 10mg
The "80" in KLOW80 refers to the total peptide content of the vial: 10 + 50 + 10 + 10 = 80mg. The name itself is generally read as the GLOW blend with a "K" added for KPV.
It is worth being clear about one point up front: the research literature studies these four compounds individually. There are no published peer-reviewed studies on the KLOW combination as a fixed blend. Everything below describes what has been reported for each component on its own, mostly in cell and animal models.
The four components and what research reports
BPC-157
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide whose sequence is derived from a protein found in gastric juice. Most of the published work comes from preclinical rodent studies, a large share of them from Professor Predrag Sikiric's group at the University of Zagreb. These studies have examined BPC-157 in models of tendon, ligament, muscle and gastrointestinal injury, and have explored its relationship with nitric oxide signalling and blood vessel formation (angiogenesis). Human data remain very limited.
For a deeper look, see our BPC-157 complete research guide, or view BPC-157 5mg / 10mg on its own.
GHK-Cu
GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. It was first isolated from human plasma by Dr Loren Pickart in the early 1970s, and plasma levels have been reported to decline with age. GHK-Cu is one of the most studied peptides in skin and wound-healing research, with laboratory work reporting effects on collagen and glycosaminoglycan synthesis and on the expression of a large number of genes linked to tissue remodelling.
GHK-Cu makes up the largest share of a KLOW vial by weight (50mg of 80mg). Read more in GHK-Cu and collagen research or see GHK-Cu 50mg / 100mg.
TB-500
TB-500 is a synthetic peptide modelled on the active, actin-binding region of thymosin beta-4 (Tβ4), a 43-amino-acid protein present in most human cells. Thymosin beta-4 regulates actin, a key part of the cell's internal skeleton, and has been studied for its role in cell migration, wound repair and the formation of new blood vessels. A widely cited 2004 study in Nature (Bock-Marquette and colleagues) reported that thymosin beta-4 supported cardiac cell survival and repair in a mouse model.
See our TB-500 research guide or TB-500 5mg / 10mg.
KPV
KPV is a tripeptide (lysine-proline-valine) that corresponds to the C-terminal end of alpha-melanocyte-stimulating hormone (α-MSH), a hormone known for its anti-inflammatory activity. A 2008 study by Dalmasso and colleagues in Gastroenterology reported that KPV is taken up into intestinal cells through the PepT1 transporter and reduced markers of inflammation in mouse models of colitis, with reduced NF-κB pathway activation reported in cell work.
KPV is what separates KLOW from GLOW. Learn more in our KPV research explainer or see KPV 10mg.
Why researchers look at these compounds together
The interest in blends like KLOW comes from the idea that the four compounds have been studied in different, partly complementary areas of tissue biology:
- BPC-157 — studied in angiogenesis and nitric oxide signalling models.
- TB-500 — studied for actin regulation and cell migration.
- GHK-Cu — studied for extracellular matrix and collagen synthesis.
- KPV — studied for inflammatory signalling, particularly in the gut.
That is a hypothesis about how the components might relate, not a demonstrated result. Because the blend itself has not been studied, any combined effect, whether additive, synergistic or neutral, is unknown. Researchers designing combination work usually include single-compound control groups so that each component's contribution can be separated. Our article on how peptide stacks are designed in research covers this in more detail.
KLOW vs GLOW: what's the difference?
The GLOW blend contains three of the four KLOW components. The only difference is KPV.
| Component | GLOW70 | KLOW80 |
|---|---|---|
| BPC-157 | 10mg | 10mg |
| GHK-Cu | 50mg | 50mg |
| TB-500 | 10mg | 10mg |
| KPV | — | 10mg |
| Total | 70mg | 80mg |
If a research protocol does not involve inflammatory-pathway questions, the GLOW70 blend may be the simpler choice. If KPV's area of research is relevant, KLOW adds it without a separate vial.
Blend or individual vials?
A pre-combined vial is convenient, but it fixes the ratio between components. Some points to weigh:
- Convenience: one vial to reconstitute, label and store instead of four.
- Fixed ratios: you cannot change the amount of one component without changing the others.
- Controls: studies that need to isolate each compound's contribution will usually need the individual peptides as well.
- Cost: compare the blend price against buying each peptide separately for the quantities your protocol needs.
Optic Labs stocks every KLOW component individually: BPC-157, GHK-Cu, TB-500 and KPV, as well as the two-peptide BPC-157 + TB-500 blend.
Handling and storage in the lab
Like other lyophilised peptides, a KLOW vial arrives as a dry powder and is reconstituted in the lab before use. Most labs use bacteriostatic (BAC) water for multi-use vials; our guide to bacteriostatic water explains why. Because a blend contains several peptides, it helps to calculate the concentration of each component separately once the vial is reconstituted. Our free peptide calculator handles the concentration maths.
Unreconstituted vials are best kept cold, dry and away from light. Once reconstituted, refrigerate and avoid repeated freeze-thaw cycles. GHK-Cu gives reconstituted KLOW and GLOW solutions a blue tint, which is normal for copper peptides. Full details are in our peptide storage guide.
Buying a KLOW blend in Australia: what to check
- Stated amounts: the label should list each component and its quantity, not just a total.
- Independent testing: look for third-party HPLC results and a certificate of analysis (COA) for the specific batch. Optic Labs publishes batch results in our COA library.
- Local stock: peptides shipped from within Australia avoid long international transit and customs delays.
- Research-use positioning: reputable suppliers sell these compounds for laboratory research only. Our guide to peptides and TGA rules in Australia explains the regulatory background.
Frequently asked questions
What does KLOW stand for?
KLOW is an informal name rather than an acronym with an official meaning. It is generally understood as the GLOW blend (BPC-157, GHK-Cu and TB-500) with KPV added, hence the "K".
What is in the KLOW80 peptide blend?
KLOW80 contains BPC-157 (10mg), GHK-Cu (50mg), TB-500 (10mg) and KPV (10mg), for 80mg of total peptide content in one vial.
Has the KLOW blend been studied in clinical trials?
No. Each component has its own body of published research, mainly preclinical, but the four-peptide blend has not been the subject of published peer-reviewed studies or clinical trials.
What is the difference between KLOW and GLOW?
GLOW contains BPC-157, GHK-Cu and TB-500 (70mg total). KLOW contains the same three plus 10mg of KPV (80mg total).
Why is reconstituted KLOW blue?
The copper in GHK-Cu gives the solution a blue colour. This is expected for any blend containing GHK-Cu.
Where can I buy a KLOW peptide blend in Australia?
Optic Labs supplies the KLOW80 blend from Sydney with third-party HPLC testing and a batch COA. You can also browse our full range of research peptides in Australia.
This article is for educational and research purposes only. Optic Labs products are intended for research use only and are not for human consumption. Always consult a qualified healthcare professional before considering any compounds.